FDA premarket rejections have surged since the February 2026 cybersecurity guidance. Espinosa speaks at MedTech World
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.